Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000417) titled 'Electroacupuncture for Amnestic Mild Cognitive Impairment: A Randomized ... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000060742) titled 'VR Cardiac Surgery Team Training Study' on Feb. 25. Study Type: Inter... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000405) titled 'Study on Imaging Characteristics of Coronary Artery CTA in Coronary Hear... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000421) titled 'Exploring the clinical efficacy of spleen-enhancing and blood-activating... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000410) titled 'The Study on the Therapeutic Effects of VEGF and NFL-based Macherin Caps... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000407) titled 'Effect of cervical paratransverse acupuncture on attentional network fun... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000412) titled 'Research on the Clinical Standardized Application of the Xiaodao-Huaji M... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (DRKS00038217) titled 'An open-label, mono center study to evaluate the feasibility of fecal microb... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (DRKS00039061) titled 'The Effects of Mood on Observers' Initial Evaluation of the Therapeutic Rela... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (KCT0011650) titled 'A Phase II Study of Cetuximab in TERT Promoter Mutant Oral Cavity Cancer After... Read More